MedPath

Homeopathic treatment of depression in aged people

Phase 2
Conditions
Health Condition 1: F330- Major depressive disorder, recurrent, mildHealth Condition 2: F331- Major depressive disorder, recurrent, moderateHealth Condition 3: F320- Major depressive disorder, singleepisode, mildHealth Condition 4: F321- Major depressive disorder, singleepisode, moderate
Registration Number
CTRI/2024/03/064364
Lead Sponsor
D. N. De Homoeopathic Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

A. Elderly people with depression of not less than two weeks duration, with a minimum of two

typical and two common symptoms will be included in the study.

• Typical symptoms:

o Depressed mood

o Loss of interest and enjoyment.

o Increased fatigability and diminished activity

• Common symptoms:

o Reduced concentration and attention.

o Reduced self-esteem and self-confidence.

o Guilt feeling and unworthiness (mild type of episode)

o Bleak and pessimistic view of the future.

o Disturbed Sleep

o Diminished appetite

B. Age above 60 years

C. Mild and moderate depression [HDRS score - 8-13 mild, 14-18 moderate]

D. GDS-15 score more than 5

E. Participants having prior experience or knowledge of the treatment; e.g., primed to expect

‘homoeopathic aggravation’ and available treatment options for the disease conditions, intimated

through Patient Information Sheet.

Exclusion Criteria

A. Mood disturbance when associated with bipolar affective disorder, schizophrenia,

schizophreniform disorder, schizoaffective disorder, or psychotic disorder.

B. Severe dementia (MoCA score less than 10)

C. Currently receiving any effective anti-depressant.

D. Active suicidal

E. Uncontrolled systemic disorders.

F. Undergoing homoeopathic treatment for any chronic disease within the last six months.

G. Vulnerable population- Unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, mentally incompetent people.

H. Self-reported immune-compromised state.

I. Patients with the habit of tobacco chewing and/or smoking, alcoholism, and/or

any other form(s) of substance abuse and/or dependence.

J. Simultaneous participation in any other clinical trials

K. Not Providing with written informed consent to participate voluntarily

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath